Q4 2024 Holdings
Filed 2025-02-14 | 60 holdings | $1.2B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $187.2M | 4,279,464 | 15.9% |
| Springworks Therapeutics Inc | COM | 85205L107 | $123.6M | 3,421,541 | 10.5% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $87.7M | 1,120,192 | 7.5% |
| Merus N V | COM | N5749R100 | $79.9M | 1,900,000 | 6.8% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $50.2M | 1,727,388 | 4.3% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $45.5M | 1,426,000 | 3.9% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $39.8M | 470,000 | 3.4% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $32.4M | 750,000 | 2.8% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $32.1M | 10,380,999 | 2.7% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $28.2M | 2,027,678 | 2.4% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $23.9M | 1,602,200 | 2.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $23.5M | 600,000 | 2.0% |
| Legend Biotech Corp(LEGN) | SPONSORED ADS | 52490G102 | $22.8M | 700,000 | 1.9% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $21.8M | 1,796,341 | 1.9% |
| Geron Corp(GERN) | COM | 374163103 | $21.2M | 6,000,000 | 1.8% |
| Third Harmonic Bio Inc(THRD) | COM | 88427A107 | $20.6M | 2,000,000 | 1.8% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $20.4M | 825,000 | 1.7% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $20.3M | 1,058,614 | 1.7% |
| Poseida Therapeutics Inc(PSTXUSD) | COM | 73730P108 | $19.2M | 2,000,000 | 1.6% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $18.4M | 1,466,051 | 1.6% |
| Anaptys Bio Inc(ANAB) | COM | 032724106 | $17.2M | 1,300,000 | 1.5% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $17.1M | 425,000 | 1.5% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $15.1M | 671,358 | 1.3% |
| Day One Biopharmaceuticals I(DAWN) | COM | 23954D109 | $15.1M | 1,189,943 | 1.3% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $14.0M | 1,732,571 | 1.2% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $13.6M | 500,000 | 1.2% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $13.5M | 1,590,000 | 1.1% |
| Uniqure NV(QURE) | SHS | N90064101 | $13.2M | 750,000 | 1.1% |
| Cullinan Therapeutics Inc(CGEM) | COM | 230031106 | $11.1M | 907,895 | 0.9% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $10.9M | 466,680 | 0.9% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $10.6M | 563,067 | 0.9% |
| Kodiak Sciences Inc(KOD) | COM | 50015M109 | $10.0M | 1,000,000 | 0.8% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $9.6M | 690,000 | 0.8% |
| Jasper Therapeutics Inc(JSPR) | COM NEW | 471871202 | $7.5M | 350,000 | 0.6% |
| iTeos Therapeutics Inc(5E7) | COM | 46565G104 | $7.3M | 946,915 | 0.6% |
| Chimerix Inc(CMRXEUR) | COM | 16934W106 | $7.2M | 2,060,000 | 0.6% |
| Instil Bio Inc(TIL) | COM NEW | 45783C200 | $6.8M | 355,500 | 0.6% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $6.6M | 1,750,000 | 0.6% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $5.6M | 750,000 | 0.5% |
| Climb Bio Inc(CLYM) | COM | 28658R106 | $4.7M | 2,603,190 | 0.4% |
| Summit Therapeutics Inc(SMMT) | COM | 86627T108 | $4.5M | 250,000 | 0.4% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $4.2M | 752,000 | 0.4% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $4.0M | 250,000 | 0.3% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $3.9M | 86,000 | 0.3% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $3.8M | 650,000 | 0.3% |
| Mersana Therapeutics Inc | COM | 59045L106 | $3.8M | 2,635,000 | 0.3% |
| Sana Biotechnology Inc(SANA) | COM | 799566104 | $2.5M | 1,545,000 | 0.2% |
| Bicara Therapeutics Inc(BCAX) | COM | 055477103 | $2.4M | 135,000 | 0.2% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $2.2M | 536,132 | 0.2% |
| Prelude Therapeutics Inc(PRLD) | COM | 74065P101 | $2.2M | 1,708,187 | 0.2% |